Figure 1.
Figure 1. Kaplan-Meier estimates in 28 patients with BNS treated with ibrutinib. (A) EFS on ibrutinib, (B) survival from ibrutinib initiation, and (C) survival from BNS diagnosis.

Kaplan-Meier estimates in 28 patients with BNS treated with ibrutinib. (A) EFS on ibrutinib, (B) survival from ibrutinib initiation, and (C) survival from BNS diagnosis.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal